{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:13:59Z","timestamp":1791468839509,"version":"4.3.4"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05884-y","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T07:56:24Z","timestamp":1755330984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvement"],"prefix":"10.1007","volume":"43","author":[{"given":"Burak","family":"Akgul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"At\u0131nc","family":"Tozsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Romero-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Ortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Netsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas RW","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Rassweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"5","key":"5884_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0302-2838(03)00376-2","volume":"44","author":"KM Verhamme","year":"2003","unstructured":"Verhamme KM et al (2003) Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 44(5):539\u2013545","journal-title":"Eur Urol"},{"issue":"6","key":"5884_CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099\u20131109","journal-title":"Eur Urol"},{"issue":"3","key":"5884_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43(3):289\u2013297","journal-title":"Urol Clin North Am"},{"issue":"Suppl 1","key":"5884_CR4","first-page":"1","volume":"22","author":"C Vuichoud","year":"2015","unstructured":"Vuichoud C, Loughlin KR (2015) Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 22(Suppl 1):1\u20136","journal-title":"Can J Urol"},{"issue":"1","key":"5884_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajur.2022.02.011","volume":"11","author":"B Kwun-Chung Cheng","year":"2024","unstructured":"Kwun-Chung Cheng B et al (2024) Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: perspectives from a global knowledge, attitude, and practice survey. Asian J Urol 11(1):55\u201364","journal-title":"Asian J Urol"},{"issue":"4","key":"5884_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5534\/wjmh.190076","volume":"38","author":"A Srinivasan","year":"2020","unstructured":"Srinivasan A, Wang R (2020) An update on minimally invasive surgery for benign prostatic hyperplasia: techniques, risks, and efficacy. World J Mens Health 38(4):402\u2013411","journal-title":"World J Mens Health"},{"key":"5884_CR7","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"5884_CR8","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"issue":"2","key":"5884_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","volume":"73","author":"T Knoll","year":"2018","unstructured":"Knoll T et al (2018) Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology. Eur Urol 73(2):290\u2013300","journal-title":"Eur Urol"},{"issue":"8","key":"5884_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"issue":"6","key":"5884_CR11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","volume":"190","author":"CG Roehrborn","year":"2013","unstructured":"Roehrborn CG et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol 190(6):2161\u20132167","journal-title":"J Urol"},{"issue":"1","key":"5884_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urpr.2014.08.001","volume":"2","author":"CG Roehrborn","year":"2015","unstructured":"Roehrborn CG et al (2015) Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study. Urol Pract 2(1):26\u201332","journal-title":"Urol Pract"},{"issue":"7","key":"5884_CR13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00345-018-2494-1","volume":"37","author":"KD Sievert","year":"2019","unstructured":"Sievert KD et al (2019) Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol 37(7):1353\u20131360","journal-title":"World J Urol"},{"issue":"3","key":"5884_CR14","first-page":"7772","volume":"22","author":"CG Roehrborn","year":"2015","unstructured":"Roehrborn CG et al (2015) Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22(3):7772\u20137782","journal-title":"Can J Urol"},{"issue":"3","key":"5884_CR15","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 24(3):8802\u20138813","journal-title":"Can J Urol"},{"issue":"Suppl 3","key":"5884_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bju.13666","volume":"118","author":"D Rukstalis","year":"2016","unstructured":"Rukstalis D et al (2016) 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham. BJU Int 118(Suppl 3):14\u201322","journal-title":"BJU Int"},{"issue":"1","key":"5884_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.urology.2011.10.021","volume":"79","author":"PT Chin","year":"2012","unstructured":"Chin PT et al (2012) Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 79(1):5\u201311","journal-title":"Urology"},{"issue":"2","key":"5884_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2013.01.008","volume":"64","author":"TA McNicholas","year":"2013","unstructured":"McNicholas TA et al (2013) Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol 64(2):292\u2013299","journal-title":"Eur Urol"},{"issue":"4","key":"5884_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bju.12540","volume":"113","author":"AL Cantwell","year":"2014","unstructured":"Cantwell AL et al (2014) Multicentre prospective crossover study of the \u201cprostatic urethral lift\u201d for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 113(4):615\u2013622","journal-title":"BJU Int"},{"issue":"1","key":"5884_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jsm.12333","volume":"11","author":"KT McVary","year":"2014","unstructured":"McVary KT et al (2014) Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med 11(1):279\u2013287","journal-title":"J Sex Med"},{"issue":"4","key":"5884_CR21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J Sonksen","year":"2015","unstructured":"Sonksen J et al (2015) Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 68(4):643\u2013652","journal-title":"Eur Urol"},{"issue":"2","key":"5884_CR22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000441850","volume":"96","author":"A Bozkurt","year":"2016","unstructured":"Bozkurt A et al (2016) Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Int 96(2):202\u2013206","journal-title":"Urol Int"},{"issue":"5","key":"5884_CR23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","volume":"119","author":"C Gratzke","year":"2017","unstructured":"Gratzke C et al (2017) Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 119(5):767\u2013775","journal-title":"BJU Int"},{"issue":"6","key":"5884_CR24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","volume":"197","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG et al (2017) Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol 197(6):1507\u20131516","journal-title":"J Urol"},{"issue":"9","key":"5884_CR25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.acuroe.2019.08.001","volume":"43","author":"C Cayuelas Rubio","year":"2019","unstructured":"Cayuelas Rubio C et al (2019) Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift(R) under local anaesthesia and sedation. Actas Urol\u00f3gicas Espa\u00f1olas (English Edition) 43(9):488\u2013494","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"},{"issue":"3","key":"5884_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","volume":"22","author":"D Rukstalis","year":"2019","unstructured":"Rukstalis D et al (2019) Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the medlift study. Prostate Cancer Prostatic Dis 22(3):411\u2013419","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"5884_CR27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5534\/wjmh.190015","volume":"38","author":"JH Kim","year":"2020","unstructured":"Kim JH, Lee KS, Kim TH (2020) Evaluation of clinical outcomes of prostatic urethral lift for benign prostatic hyperplasia: an Asian population study. World J Mens Health 38(3):338\u2013344","journal-title":"World J Mens Health"},{"issue":"3","key":"5884_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.purol.2020.01.003","volume":"30","author":"M Userovici","year":"2020","unstructured":"Userovici M et al (2020) Prostatic urethral lift using Urolift(R) system for benign prostatic hyperplasia: 7years experience. Prog Urol 30(3):147\u2013154","journal-title":"Prog Urol"},{"issue":"1","key":"5884_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-021-00824-5","volume":"21","author":"T Page","year":"2021","unstructured":"Page T et al (2021) Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics. BMC Urol 21(1):55","journal-title":"BMC Urol"},{"issue":"9","key":"5884_CR30","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s11255-021-02899-3","volume":"53","author":"M Baboudjian","year":"2021","unstructured":"Baboudjian M et al (2021) Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study. Int Urol Nephrol 53(9):1757\u20131763","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"5884_CR31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.purol.2021.09.003","volume":"32","author":"L Dupitout","year":"2022","unstructured":"Dupitout L et al (2022) Prostatic urethral lift under local anesthesia: single-centre retrospective observational study. Prog Urol 32(3):182\u2013188","journal-title":"Prog Urol"},{"issue":"3","key":"5884_CR32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13645706.2020.1816554","volume":"31","author":"W Al-Singary","year":"2022","unstructured":"Al-Singary W et al (2022) The urolift((R)) system for lower urinary tract obstruction: patient selection for optimum clinical outcome. Minim Invasive Ther Allied Technol 31(3):456\u2013461","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"3","key":"5884_CR33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT et al (2021) Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 206(3):715\u2013724","journal-title":"J Urol"},{"issue":"12","key":"5884_CR34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.purol.2020.05.004","volume":"30","author":"C Alegorides","year":"2020","unstructured":"Alegorides C et al (2020) Treatment of benign prostate hyperplasia using the Rezum(R) water vapor therapy system: results at one year. Prog Urol 30(12):624\u2013631","journal-title":"Prog Urol"},{"issue":"1","key":"5884_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/JU.0000000000003483","volume":"210","author":"N Bhojani","year":"2023","unstructured":"Bhojani N et al (2023) Aquablation therapy in large prostates (80\u2013150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results. J Urol 210(1):143\u2013153","journal-title":"J Urol"},{"issue":"6","key":"5884_CR36","volume":"9","author":"KT McVary","year":"2021","unstructured":"McVary KT, El-Arabi A, Roehrborn C (2021) Preservation of sexual function 5 years after water vapor thermal therapy for benign prostatic hyperplasia. Sex Med 9(6):100454","journal-title":"Sex Med"},{"issue":"5","key":"5884_CR37","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT et al (2016) Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 195(5):1529\u20131538","journal-title":"J Urol"},{"issue":"6","key":"5884_CR38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","volume":"13","author":"KT McVary","year":"2016","unstructured":"McVary KT et al (2016) Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med 13(6):924\u2013933","journal-title":"J Sex Med"},{"issue":"5","key":"5884_CR39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/iju.15410","volume":"31","author":"M Samir","year":"2024","unstructured":"Samir M et al (2024) Two-year follow-up comparing Rezum therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. Int J Urol 31(5):545\u2013550","journal-title":"Int J Urol"},{"key":"5884_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","volume":"111","author":"KT McVary","year":"2018","unstructured":"McVary KT, Roehrborn CG (2018) Three-year outcomes of the prospective, randomized controlled Rezum system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology 111:1\u20139","journal-title":"Urology"},{"key":"5884_CR41","first-page":"207","volume":"8","author":"CM Dixon","year":"2016","unstructured":"Dixon CM et al (2016) Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 8:207\u2013216","journal-title":"Res Rep Urol"},{"key":"5884_CR42","first-page":"159","volume":"9","author":"MF Darson","year":"2017","unstructured":"Darson MF et al (2017) Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with rezum system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 9:159\u2013168","journal-title":"Res Rep Urol"},{"issue":"3","key":"5884_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","volume":"21","author":"D Mollengarden","year":"2018","unstructured":"Mollengarden D et al (2018) Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis 21(3):379\u2013385","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"5884_CR44","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jsxm.2018.10.006","volume":"15","author":"KT McVary","year":"2018","unstructured":"McVary KT et al (2018) Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med 15(12):1728\u20131738","journal-title":"J Sex Med"},{"issue":"5","key":"5884_CR45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bju.15203","volume":"126","author":"MJ Johnston","year":"2020","unstructured":"Johnston MJ et al (2020) Rezum water vapour therapy: promising early outcomes from the first UK series. BJU Int 126(5):557\u2013558","journal-title":"BJU Int"},{"issue":"5","key":"5884_CR46","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/13685538.2021.1901273","volume":"23","author":"A Wong","year":"2020","unstructured":"Wong A, Mahmalji W (2020) The role of Rezum team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review. Aging Male 23(5):1620\u20131626","journal-title":"Aging Male"},{"issue":"14","key":"5884_CR47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/pros.24201","volume":"81","author":"D Bassily","year":"2021","unstructured":"Bassily D et al (2021) Rezum for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia. Prostate 81(14):1049\u20131054","journal-title":"Prostate"},{"issue":"8","key":"5884_CR48","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s00345-020-03548-7","volume":"39","author":"EB Garden","year":"2021","unstructured":"Garden EB et al (2021) Rezum therapy for patients with large prostates (>\/= 80 g): initial clinical experience and postoperative outcomes. World J Urol 39(8):3041\u20133048","journal-title":"World J Urol"},{"issue":"13","key":"5884_CR49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pros.24191","volume":"81","author":"M Ines","year":"2021","unstructured":"Ines M et al (2021) Real-world evidence with the Rezum System: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes. Prostate 81(13):956\u2013970","journal-title":"Prostate"},{"issue":"10","key":"5884_CR50","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00345-021-03642-4","volume":"39","author":"G Siena","year":"2021","unstructured":"Siena G et al (2021) Water vapor therapy (Rezum) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol 39(10):3875\u20133880","journal-title":"World J Urol"},{"key":"5884_CR51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euros.2022.03.006","volume":"39","author":"D Whiting","year":"2022","unstructured":"Whiting D et al (2022) Real-world early outcomes and retreatment rates following water vapour ablative therapy for symptomatic benign prostatic hyperplasia. Eur Urol Open Sci 39:72\u201378","journal-title":"Eur Urol Open Sci"},{"key":"5884_CR52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.urology.2022.02.001","volume":"165","author":"D Elterman","year":"2022","unstructured":"Elterman D et al (2022) Large, multi-center, prospective registry of Rezum water vapor therapy for benign prostatic hyperplasia. Urology 165:261\u2013267","journal-title":"Urology"},{"issue":"2","key":"5884_CR53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41391-021-00462-w","volume":"25","author":"K Eredics","year":"2022","unstructured":"Eredics K et al (2022) Rezum water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis 25(2):302\u2013305","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"5884_CR54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.acuro.2021.11.003","volume":"46","author":"E Fernandez-Guzman","year":"2022","unstructured":"Fernandez-Guzman E et al (2022) Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezum(R) steam system. Actas Urol Esp (Engl Ed) 46(5):310\u2013316","journal-title":"Actas Urol Esp (Engl Ed)"},{"issue":"2","key":"5884_CR55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41391-022-00587-6","volume":"26","author":"D Campobasso","year":"2023","unstructured":"Campobasso D et al (2023) Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostatic Dis 26(2):410\u2013414","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"5884_CR56","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ et al (2022) Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol 29(1):10960\u201310968","journal-title":"Can J Urol"},{"issue":"5","key":"5884_CR57","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P et al (2018) Water: a double-blind, randomized, controlled trial of Aquablation((R)) vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252\u20131261","journal-title":"J Urol"},{"issue":"5","key":"5884_CR58","first-page":"11650","volume":"30","author":"K Oumedjbeur","year":"2023","unstructured":"Oumedjbeur K et al (2023) Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50\u201380 mL. Can J Urol 30(5):11650\u201311658","journal-title":"Can J Urol"},{"issue":"5","key":"5884_CR59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eururo.2019.06.024","volume":"76","author":"V Misrai","year":"2019","unstructured":"Misrai V et al (2019) Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first French Aquablation clinical registry. Eur Urol 76(5):667\u2013675","journal-title":"Eur Urol"},{"issue":"6","key":"5884_CR60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bju.13358","volume":"117","author":"P Gilling","year":"2016","unstructured":"Gilling P et al (2016) Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int 117(6):923\u2013929","journal-title":"BJU Int"},{"issue":"6","key":"5884_CR61","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.juro.2017.01.056","volume":"197","author":"P Gilling","year":"2017","unstructured":"Gilling P, Anderson P, Tan A (2017) Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197(6):1565\u20131572","journal-title":"J Urol"},{"issue":"3","key":"5884_CR62","first-page":"9317","volume":"25","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Hussain M (2018) Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomes. Can J Urol 25(3):9317\u20139322","journal-title":"Can J Urol"},{"issue":"10","key":"5884_CR63","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00345-022-04137-6","volume":"40","author":"BL Raizenne","year":"2022","unstructured":"Raizenne BL et al (2022) Functional and surgical outcomes of Aquablation in elderly men. World J Urol 40(10):2515\u20132520","journal-title":"World J Urol"},{"key":"5884_CR64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.urology.2023.08.001","volume":"181","author":"I Sadri","year":"2023","unstructured":"Sadri I et al (2023) Aquablation in patients on antithrombotics: assessment of safety, postoperative bleeding rates and clinical outcomes. Urology 181:112\u2013118","journal-title":"Urology"},{"key":"5884_CR65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.urology.2024.07.047","volume":"194","author":"OO Omidele","year":"2024","unstructured":"Omidele OO et al (2024) Aquablation at 4-years: real world data from the largest single-center study with associated outcomes follow-up. Urology 194:216\u2013220","journal-title":"Urology"},{"key":"5884_CR66","volume":"361","author":"D Abt","year":"2018","unstructured":"Abt D et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 361:k2338","journal-title":"BMJ"},{"issue":"1","key":"5884_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2021.02.008","volume":"80","author":"D Abt","year":"2021","unstructured":"Abt D et al (2021) Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial. Eur Urol 80(1):34\u201342","journal-title":"Eur Urol"},{"issue":"1","key":"5884_CR68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC et al (2016) Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol 39(1):44\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"5884_CR69","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jvir.2019.06.019","volume":"30","author":"T Bilhim","year":"2019","unstructured":"Bilhim T et al (2019) Randomized clinical trial of balloon occlusion versus conventional microcatheter prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 30(11):1798\u20131806","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"5884_CR70","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2019.11.010","volume":"77","author":"JM Pisco","year":"2020","unstructured":"Pisco JM et al (2020) Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol 77(3):354\u2013362","journal-title":"Eur Urol"},{"key":"5884_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101871","author":"T Jankauskas","year":"2023","unstructured":"Jankauskas T et al (2023) Prostatic artery embolization as a treatment option for symptomatic benign prostatic hyperplasia: results from the prospective follow-up study in Lithuania. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59101871","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"5884_CR72","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jvir.2019.02.014","volume":"30","author":"D Torres","year":"2019","unstructured":"Torres D et al (2019) Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100\u2013300 mum versus 300\u2013500 mum versus 100- to 300-mum + 300- to 500-mum embospheres. J Vasc Interv Radiol 30(5):638\u2013644","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"5884_CR73","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jvir.2019.12.810","volume":"31","author":"I Insausti","year":"2020","unstructured":"Insausti I et al (2020) Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 31(6):882\u2013890","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"5884_CR74","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1148\/radiol.13122803","volume":"270","author":"YA Gao","year":"2014","unstructured":"Gao YA et al (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate\u2013a prospective, randomized, and controlled clinical trial. Radiology 270(3):920\u2013928","journal-title":"Radiology"},{"issue":"2","key":"5884_CR75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bju.14249","volume":"122","author":"AF Ray","year":"2018","unstructured":"Ray AF et al (2018) Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 122(2):270\u2013282","journal-title":"BJU Int"},{"key":"5884_CR76","volume":"31","author":"M Sapoval","year":"2023","unstructured":"Sapoval M et al (2023) Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur 31:100672","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"5884_CR77","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-024-08409-x","volume":"25","author":"A Kristensen-Alvarez","year":"2024","unstructured":"Kristensen-Alvarez A et al (2024) Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial. Trials 25(1):574","journal-title":"Trials"},{"issue":"8","key":"5884_CR78","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00345-023-04473-1","volume":"41","author":"M Pichardo","year":"2023","unstructured":"Pichardo M et al (2023) Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study. World J Urol 41(8):2209\u20132215","journal-title":"World J Urol"},{"key":"5884_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00833-z","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA, Moss JL, Freedman SJ (2024) Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (the PINNACLE study). Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-024-00833-z","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"5884_CR80","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JU.0000000000003568","volume":"210","author":"SA Kaplan","year":"2023","unstructured":"Kaplan SA et al (2023) The PINNACLE study: a double-blind, randomized, sham-controlled study evaluating the Optilume BPH catheter system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 210(3):500\u2013509","journal-title":"J Urol"},{"issue":"11","key":"5884_CR81","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.5489\/cuaj.8737","volume":"18","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA et al (2024) Long-term outcomes after treatment with Optilume BPH four-year results from the EVEREST study. Can Urol Assoc J 18(11):E319\u2013E325","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"5884_CR82","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41391-021-00362-z","volume":"24","author":"SA Kaplan","year":"2021","unstructured":"Kaplan SA et al (2021) One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 24(4):1073\u20131079","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"5884_CR83","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","volume":"123","author":"F Porpiglia","year":"2019","unstructured":"Porpiglia F et al (2019) Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int 123(6):1061\u20131069","journal-title":"BJU Int"},{"issue":"2","key":"5884_CR84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41391-020-00281-5","volume":"24","author":"D Amparore","year":"2021","unstructured":"Amparore D et al (2021) 3-year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis 24(2):349\u2013357","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"5884_CR85","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00345-020-03140-z","volume":"38","author":"G Kadner","year":"2020","unstructured":"Kadner G et al (2020) Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study. World J Urol 38(12):3235\u20133244","journal-title":"World J Urol"},{"issue":"6","key":"5884_CR86","first-page":"743","volume":"75","author":"D Amparore","year":"2023","unstructured":"Amparore D et al (2023) Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results. Minerva Urol Nefrol 75(6):743\u2013751","journal-title":"Minerva Urol Nefrol"},{"key":"5884_CR87","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B et al (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology 153:270\u2013276","journal-title":"Urology"},{"issue":"6","key":"5884_CR88","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00345-020-03418-2","volume":"39","author":"C De Nunzio","year":"2021","unstructured":"De Nunzio C et al (2021) Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol 39(6):2037\u20132042","journal-title":"World J Urol"},{"issue":"3","key":"5884_CR89","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.juro.2006.10.024","volume":"177","author":"MK Plante","year":"2007","unstructured":"Plante MK et al (2007) Phase I\/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 177(3):1030\u20131035 (discussion 1035)","journal-title":"J Urol"},{"issue":"5","key":"5884_CR90","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00005392-199805000-00048","volume":"159","author":"R Bruskewitz","year":"1998","unstructured":"Bruskewitz R et al (1998) A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 159(5):1588\u20131593","journal-title":"J Urol"},{"issue":"5","key":"5884_CR91","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0022-5347(01)64140-5","volume":"158","author":"GS Steele","year":"1997","unstructured":"Steele GS, Sleep DJ (1997) Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol 158(5):1834\u20131838","journal-title":"J Urol"},{"issue":"2","key":"5884_CR92","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/UA.UA_99_18","volume":"11","author":"H Haroun","year":"2019","unstructured":"Haroun H et al (2019) Evaluation of outcome of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia: a 10-year experience. Urol Ann 11(2):198\u2013203","journal-title":"Urol Ann"},{"issue":"2","key":"5884_CR93","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0090-4295(02)01704-1","volume":"60","author":"MJ Leskinen","year":"2002","unstructured":"Leskinen MJ et al (2002) Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology 60(2):300\u2013304","journal-title":"Urology"},{"issue":"3","key":"5884_CR94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.juro.2006.10.042","volume":"177","author":"DJ Rosario","year":"2007","unstructured":"Rosario DJ, Phillips JT, Chapple CR (2007) Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. J Urol 177(3):1047\u20131051","journal-title":"J Urol"},{"issue":"7","key":"5884_CR95","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1442-2042.2003.00648.x","volume":"10","author":"K Fujimoto","year":"2003","unstructured":"Fujimoto K et al (2003) Variations of transition zone volume and transition zone index after transurethral needle ablation for symptomatic benign prostatic hyperplasia. Int J Urol 10(7):392\u2013397","journal-title":"Int J Urol"},{"issue":"2","key":"5884_CR96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-5347(01)61930-X","volume":"161","author":"EA Francisca","year":"1999","unstructured":"Francisca EA et al (1999) Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 161(2):486\u2013490","journal-title":"J Urol"},{"issue":"5","key":"5884_CR97","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-5347(05)66343-4","volume":"165","author":"DL Floratos","year":"2001","unstructured":"Floratos DL et al (2001) Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 165(5):1533\u20131538","journal-title":"J Urol"},{"issue":"3","key":"5884_CR98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1442-2042.2002.00439.x","volume":"9","author":"T Ohigashi","year":"2002","unstructured":"Ohigashi T et al (2002) Long-term effects of transurethral microwave thermotherapy. Int J Urol 9(3):141\u2013145","journal-title":"Int J Urol"},{"issue":"1","key":"5884_CR99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1464-410X.1997.00245.x","volume":"80","author":"J Ramon","year":"1997","unstructured":"Ramon J et al (1997) Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol 80(1):128\u2013134","journal-title":"Br J Urol"},{"issue":"3","key":"5884_CR100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0090-4295(97)00682-1","volume":"51","author":"CG Roehrborn","year":"1998","unstructured":"Roehrborn CG et al (1998) Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 51(3):415\u2013421","journal-title":"Urology"},{"issue":"6","key":"5884_CR101","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1159\/000020220","volume":"37","author":"G Schatzl","year":"2000","unstructured":"Schatzl G et al (2000) Two-year results of transurethral resection of the prostate versus four \u201cless invasive\u201d treatment options. Eur Urol 37(6):695\u2013701","journal-title":"Eur Urol"},{"issue":"3","key":"5884_CR102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1442-2042.2001.00260.x","volume":"8","author":"M Murai","year":"2001","unstructured":"Murai M et al (2001) Transurethral needle ablation of the prostate: an initial Japanese clinical trial. Int J Urol 8(3):99\u2013105","journal-title":"Int J Urol"},{"issue":"2","key":"5884_CR103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/08927790360587432","volume":"17","author":"E Cimentepe","year":"2003","unstructured":"Cimentepe E, Unsal A, Saglam R (2003) Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 17(2):103\u2013107","journal-title":"J Endourol"},{"issue":"6 Pt 1","key":"5884_CR104","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1097\/01.ju.0000127761.87421.a0","volume":"171","author":"B Hill","year":"2004","unstructured":"Hill B et al (2004) Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171(6 Pt 1):2336\u20132340","journal-title":"J Urol"},{"issue":"4","key":"5884_CR105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2004.06.001","volume":"46","author":"P Grise","year":"2004","unstructured":"Grise P et al (2004) Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol 46(4):496\u2013501","journal-title":"Eur Urol"},{"issue":"5","key":"5884_CR106","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.1995.tb07788.x","volume":"76","author":"C Dahlstrand","year":"1995","unstructured":"Dahlstrand C et al (1995) Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 76(5):614\u2013618","journal-title":"Br J Urol"},{"issue":"3","key":"5884_CR107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/003655998750015584","volume":"32","author":"M Walden","year":"1998","unstructured":"Walden M et al (1998) A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up. Scand J Urol Nephrol 32(3):204\u2013210","journal-title":"Scand J Urol Nephrol"},{"issue":"7","key":"5884_CR108","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1464-410X.2003.04470.x","volume":"92","author":"JJ De La Rosette","year":"2003","unstructured":"De La Rosette JJ et al (2003) Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 92(7):713\u2013718","journal-title":"BJU Int"},{"issue":"4","key":"5884_CR109","first-page":"103","volume":"17","author":"Y Sahakyan","year":"2023","unstructured":"Sahakyan Y et al (2023) Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective. Can Urol Assoc J 17(4):103\u2013110","journal-title":"Can Urol Assoc J"},{"key":"5884_CR110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"KT McVary","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG (2019) Rezum water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 126:171\u2013179","journal-title":"Urology"},{"issue":"1","key":"5884_CR111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/end.2022.0226","volume":"37","author":"D Elterman","year":"2023","unstructured":"Elterman D et al (2023) An evaluation of sexual function in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia in men treated with the temporarily implanted Nitinol device. J Endourol 37(1):74\u201379","journal-title":"J Endourol"},{"issue":"1","key":"5884_CR112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1464-410X.2010.09737.x","volume":"108","author":"J Izard","year":"2011","unstructured":"Izard J, Nickel JC (2011) Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 108(1):89\u201393","journal-title":"BJU Int"},{"issue":"5","key":"5884_CR113","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J et al (2006) Complications of transurethral resection of the prostate (TURP)\u2013incidence, management, and prevention. Eur Urol 50(5):969\u2013979","journal-title":"Eur Urol"},{"issue":"11","key":"5884_CR114","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00270-021-02920-3","volume":"44","author":"F Capdevila","year":"2021","unstructured":"Capdevila F et al (2021) Prostatic artery embolization versus transurethral resection of the prostate: a post hoc cost analysis of a randomized controlled clinical trial. Cardiovasc Intervent Radiol 44(11):1771\u20131777","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"5884_CR115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1464-410X.1997.00414.x","volume":"80","author":"DJ Rosario","year":"1997","unstructured":"Rosario DJ et al (1997) Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 80(4):579\u2013586","journal-title":"Br J Urol"},{"issue":"1","key":"5884_CR116","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005392-199907000-00023","volume":"162","author":"CG Roehrborn","year":"1999","unstructured":"Roehrborn CG et al (1999) The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 162(1):92\u201397","journal-title":"J Urol"},{"issue":"4","key":"5884_CR117","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-5347(05)67142-X","volume":"164","author":"Y Arai","year":"2000","unstructured":"Arai Y et al (2000) Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 164(4):1206\u20131211","journal-title":"J Urol"},{"key":"5884_CR118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.urology.2021.10.025","volume":"159","author":"A Singh","year":"2022","unstructured":"Singh A et al (2022) Association between industry payments and published position on use of devices for the treatment of lower urinary tract symptoms. Urology 159:87\u201392","journal-title":"Urology"},{"issue":"9","key":"5884_CR119","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00345-022-04098-w","volume":"40","author":"AM Durant","year":"2022","unstructured":"Durant AM et al (2022) Salvage versus primary holmium laser enucleation of the prostate: trends, outcomes and safety analysis. World J Urol 40(9):2305\u20132312","journal-title":"World J Urol"},{"key":"5884_CR120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.urology.2022.09.026","volume":"171","author":"KM Wymer","year":"2023","unstructured":"Wymer KM et al (2023) Evaluation of the cost-effectiveness of surgical treatment options for benign prostatic hyperplasia. Urology 171:96\u2013102","journal-title":"Urology"},{"key":"5884_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.09.004","author":"B Akgul","year":"2024","unstructured":"Akgul B et al (2024) Development of a Bladder Injury Classification System for Endoscopic Procedures: A Mixed-methods Study Involving Expert Consensus and Validation. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2024.09.004","journal-title":"Eur Urol Focus"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05884-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05884-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05884-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:04:11Z","timestamp":1767996251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05884-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5884"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05884-y","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was needed since this study is a systematic literature review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"494"}}